Literature DB >> 35726046

Should patients skip late doses of medication? A pharmacokinetic perspective.

Elias D Clark1, Sean D Lawley2.   

Abstract

Missed doses, late doses, and other dosing irregularities are major barriers to effective pharmacotherapy, especially for the treatment of chronic conditions. What should a patient do if they did not take their last dose at the prescribed time? Should they take it late or skip it? In this paper, we investigate the pharmacokinetic effects of taking a late dose. We consider a single compartment model with linear absorption and elimination for a patient instructed to take doses at regular time intervals. We suppose that the patient forgets to take a dose and then realizes some time later and must decide what remedial steps to take. Using mathematical analysis, we derive several metrics which quantify the effects of taking the dose late. The metrics involve the difference between the drug concentration time courses for the case that the dose is taken late and the case that the dose is taken on time. In particular, the metrics are the integral of the absolute difference over all time, the maximum of the difference, and the maximum of the integral of the difference over any single dosing interval. We apply these general mathematical formulas to levothyroxine, atorvastatin, and immediate release and extended release formulations of lamotrigine. We further show how population variability can be immediately incorporated into these results. Finally, we use this analysis to propose general principles and strategies for dealing with dosing irregularities.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Late dose; Mathematical model; Missed dose; Nonadherence

Mesh:

Substances:

Year:  2022        PMID: 35726046     DOI: 10.1007/s10928-022-09812-0

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.410


  23 in total

1.  Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.

Authors:  Scott T Brittain; James W Wheless
Journal:  Epilepsy Behav       Date:  2015-09-24       Impact factor: 2.937

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 3.  Dosing frequency and medication adherence in chronic disease.

Authors:  Craig I Coleman; Brendan Limone; Diana M Sobieraj; Soyon Lee; Matthew S Roberts; Rajbir Kaur; Tawfikul Alam
Journal:  J Manag Care Pharm       Date:  2012-09

4.  Factors associated with medication adherence in patients with epilepsy and recommendations for improvement.

Authors:  Angelia M Paschal; Sarah E Rush; Toni Sadler
Journal:  Epilepsy Behav       Date:  2013-11-17       Impact factor: 2.937

5.  The relationship between poor medication compliance and seizures.

Authors:  Joyce A. Cramer; Marc Glassman; Vincent Rienzi
Journal:  Epilepsy Behav       Date:  2002-08       Impact factor: 2.937

6.  What is a missed dose? Implications for construct validity and patient adherence.

Authors:  A P Sankar; D C Nevedal; S Neufeld; M R Luborsky
Journal:  AIDS Care       Date:  2007-07

7.  In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines.

Authors:  Sara L Thier; Kristina S Yu-Isenberg; Brian F Leas; C Ron Cantrell; Sandra DeBussey; Neil I Goldfarb; David B Nash
Journal:  Manag Care       Date:  2008-02

Review 8.  How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective.

Authors:  Jia-Qin Gu; Yun-Peng Guo; Zheng Jiao; Jun-Jie Ding; Guo-Fu Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

9.  The ethics of placebo-controlled trials: methodological justifications.

Authors:  Joseph Millum; Christine Grady
Journal:  Contemp Clin Trials       Date:  2013-09-12       Impact factor: 2.226

10.  Is There a Threshold for Medication Adherence? Lessons Learnt From Electronic Monitoring of Drug Adherence.

Authors:  Michel Burnier
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.